Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Cohen-Wolkowiez, MD
Duke Clinical Research Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Plovdiv, Bulgaria
- Facility name not stated
Rousse, Bulgaria
- Facility name not stated
Sofia, Bulgaria
- Facility name not stated
Little Rock, Arkansas, United States
- Facility name not stated
Orange, California, United States
- Facility name not stated
Palo Alto, California, United States
- Facility name not stated
San Diego, California, United States
- Facility name not stated
Jacksonville, Florida, United States
- Facility name not stated
Tampa, Florida, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Iowa City, Iowa, United States
- Facility name not stated
Wichita, Kansas, United States
- Facility name not stated
Louisville, Kentucky, United States
- Facility name not stated
Shreveport, Louisiana, United States
- Facility name not stated
Baltimore, Maryland, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Omaha, Nebraska, United States
- Facility name not stated
Hackensack, New Jersey, United States
- Facility name not stated
Albuquerque, New Mexico, United States
- Facility name not stated
Albany, New York, United States
- Facility name not stated
Brooklyn, New York, United States
- Facility name not stated
Chapel Hill, North Carolina, United States
- Facility name not stated
Cleveland, Ohio, United States
- Facility name not stated
Toledo, Ohio, United States
- Facility name not stated
Portland, Oregon, United States
- Facility name not stated
Memphis, Tennessee, United States
- Facility name not stated
Nashville, Tennessee, United States
- Facility name not stated
Austin, Texas, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
Splendora, Texas, United States
- Facility name not stated
Richmond, Virginia, United States
- Facility name not stated
Seattle, Washington, United States
- Facility name not stated
Morgantown, West Virginia, United States
- Facility name not stated
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2015
- Primary completion
- 31 Oct 2016
- Completion
- 31 Oct 2016
- Last update posted
- 9 Jun 2017
- Registered enrollment
- 84
- Registry id
- NCT02268279
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.